Clinical Trial Update: Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of FRSW107 in pediatric patients with Hemophilia A; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• FRSW107

Snippet

Sponsor: Jiangsu Gensciences lnc. | Conditions: Severe Hemophilia A | Phase 3 | Status: NOT_YET_RECRUITING